CEO of largest public hospital says he's ready to replace radiologists with AI
A U.S. hospital executive’s claim that AI can replace many radiologists, citing very low false‑negative rates in breast cancer screening, has triggered broader debate over how far medical imaging can be safely automated. Commenters question the underlying accuracy data, highlight medicolegal and insurance liabilities if AI makes mistakes, and argue that current systems are better suited to assisting radiologists than fully substituting for them. The exchange also widens into criticism of cost-cutting motives in healthcare and speculation about whether executive and administrative roles themselves could be automated before highly specialized clinicians.
Diagnostic accuracy & risk tradeoffs
- The quoted claim that an AI mammography system is wrong “3 in 10,000” for low‑risk women raises multiple questions: how that was measured, on what dataset, and compared to what human baseline.
- Several ask specifically for human false‑negative rates and performance in high‑risk populations; one link suggests human false negatives around 10 in 10,000 in some contexts.
- Commenters stress that false negatives in cancer are life‑threatening, but excessive false positives also cause harm (unnecessary biopsies/surgeries), so risk must be balanced.
- Some fear marketing cherry‑picks simple cases; complex anatomy, multiple pathologies, and rare presentations may be where AI fails most.
Augment vs replace radiologists
- Many advocate AI as a second reader or triage tool, not a full replacement: double reads (AI + human), “blind workflows” where each reads independently then reconciles, etc.
- A practicing radiologist argues current AI cannot replace them, that radiology is more than pattern recognition, and full replacement would require AGI.
- Others see a likely outcome where top radiologists, aided by AI, handle far more volume, pressuring the rest of the workforce.
Legal, liability, and standard of care
- Strong concern about who is sued when AI misses a diagnosis if no physician signs off: hospital, CEO, vendor?
- Some propose laws making everyone in the approval chain prima facie liable, including AI vendors.
- Others note malpractice law follows “standard of care”: if AI becomes standard and a doctor ignores it, that can itself be malpractice.
Economic incentives and reimbursement
- Commenters view the CEO’s remarks as primarily cost‑cutting and negotiating leverage against radiology groups, not patient‑centric.
- Several predict insurers will eventually pay less for AI reads than for human interpretation, eroding hospital cost savings.
- Malpractice insurance dynamics and potential insurer pushback against unsafe AI use are noted but seen as slow‑acting constraints.
Debate over evidence and AI performance
- One commenter cites very low human detection rates for some subtle findings; others strongly challenge these numbers and demand sources.
- This sparks a meta‑discussion: if you give precise statistics, you should provide evidence; unsourced bold claims are treated skeptically.
Broader implications: CEOs, HR, and access
- Many argue AI could more easily replace CEOs or HR than radiologists, and suggest that if executives felt personally automatable, they might treat AI impacts on workers differently.
- Some imagine AI‑run co‑ops or nonprofits with lower overhead.
- In systems with multi‑year wait times, several would accept AI screening as an initial step despite risks, while others emphasize the danger of both false positives and negatives.